In addition, there are many reports about the concentration of VEGF after anti-VEGF therapy for age-related macular degeneration and state that the systemic VEGF concentration after treatment differs for the different anti-VEGF agents24–26. The gene discussed is VEGFA; the disease is age-related macular degeneration.